Articles
| Open Access |
https://doi.org/10.55640/
DRUG-RESISTANT TUBERCULOSIS
Batirova Barchinoy Tadzhimukhammadovna , Andijan State Medical Institute Assistant, Department of Phthisiology and Pulmonology MicrobiologyAbstract
This article provides information about drug-resistant tuberculosis (MDR-TB). Drug-resistant tuberculosis occurs when mycobacteria become resistant to the main antituberculosis drugs. This disease, unlike regular tuberculosis, is much more difficult to treat and requires long-term special drugs. The article provides detailed information about the clinical signs, diagnosis, treatment methods and prevention of drug-resistant tuberculosis. Early detection and proper treatment of tuberculosis are important in preventing drug-resistant forms of tuberculosis.
Keywords
Drug-resistant tuberculosis, Tuberculosis, MDR-TB Mycobacteria, Antituberculosis drugs, Tuberculosis, Resistant mycobacteria, Clinical signs of tuberculosis, Diagnostics, Treatment methods, Prophylaxis, Prevention of tuberculosis.
References
World Health Organization (WHO). (2024). "Global Tuberculosis Report". https://www.who.int/tb/publications/global_report/en/
"Doctors Without Borders" (MSF). (2024). "Combating Multi-Drug-Resistant Tuberculosis (MDR-TB)". https://msf.org.uk/tb-practecal-ozbek
Daryo.uz. (2024). "Global Health Organization and Tuberculosis Prevention". https://daryo.uz/2024/03/25/global-soglqin-saqlash-organipokistondagi-sil-kasalligining-75-foizi-aniqlnamgan
Doctors Network. (2024). "Drug-Resistant Tuberculosis: Diagnosis and Treatment". https://www.shifokor.uz/tuberkulyoz
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.